Guardant Health
GH
#1001
Rank
ยฃ18.06 B
Marketcap
ยฃ134.58
Share price
1.75%
Change (1 day)
185.25%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -ยฃ2.61

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -ยฃ2.64. In 2025 the company made an earnings per share (EPS) of -ยฃ2.51 an increase over its 2024 EPS that were of -ยฃ2.69.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ2.614.34%
2025-ยฃ2.51-7.02%
2024-ยฃ2.69-16.82%
2023-ยฃ3.24-33.12%
2022-ยฃ4.8460%
2021-ยฃ3.0355.04%
2020-ยฃ1.95207.14%
2019-ยฃ0.64-19.81%
2018-ยฃ0.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-ยฃ0.02723-98.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-ยฃ1.85-29.80%๐Ÿ‡บ๐Ÿ‡ธ USA